iShares Global Healthcare ETF (IXJ) Dividends
IXJ Dividend History
Ex-Dividend Date | Type | Payout Amount | Change |
---|---|---|---|
2024-06-11 | Dividend | $0.67 | +20.86% |
2023-12-20 | Dividend | $0.56 | -13.66% |
2023-06-07 | Dividend | $0.64 | +46.36% |
2022-12-13 | Dividend | $0.44 | -20.15% |
2022-06-09 | Dividend | $0.55 | +14.32% |
2021-12-13 | Dividend | $0.48 | -9.57% |
2021-06-10 | Dividend | $0.53 | +21.41% |
2020-12-14 | Dividend | $0.44 | -17.79% |
2020-06-15 | Dividend | $0.53 | +11.48% |
2019-12-16 | Dividend | $0.48 | -3.62% |
2019-06-17 | Dividend | $0.50 | -25.15% |
2018-12-28 | Dividend | $0.66 | +91.35% |
2018-12-18 | Dividend | $0.35 | -33.01% |
2018-06-19 | Dividend | $0.52 | +57.58% |
2018-05-02 | Split | 2-1-for-1 Stock Split | N/A |
2017-12-21 | Dividend | $0.66 | -33.10% |
2017-06-20 | Dividend | $0.99 | +36.46% |
2016-12-22 | Dividend | $0.72 | -20.87% |
2016-06-21 | Dividend | $0.92 | +348.53% |
2015-12-29 | Dividend | $0.20 | -73.09% |
2015-12-21 | Dividend | $0.76 | -9.74% |
2015-06-24 | Dividend | $0.84 | +117.68% |
2014-12-19 | Dividend | $0.39 | -60.79% |
2014-06-24 | Dividend | $0.98 | +149.68% |
2013-12-17 | Dividend | $0.39 | -56.40% |
2013-06-25 | Dividend | $0.90 | +72.61% |
2012-12-17 | Dividend | $0.52 | -44.65% |
2012-06-20 | Dividend | $0.95 | +124.04% |
2011-12-19 | Dividend | $0.42 | -46.91% |
2011-06-21 | Dividend | $0.80 | +97.81% |
2010-12-20 | Dividend | $0.40 | -45.53% |
2010-06-21 | Dividend | $0.74 | +139.53% |
2009-12-21 | Dividend | $0.31 | -56.97% |
2009-06-22 | Dividend | $0.72 | +116.31% |
2008-12-22 | Dividend | $0.33 | -51.82% |
2008-06-23 | Dividend | $0.69 | -31.57% |
2007-12-24 | Dividend | $1.00 | +106.16% |
2006-12-21 | Dividend | $0.49 | +32.34% |
2005-12-23 | Dividend | $0.37 | +1.10% |
2004-12-23 | Dividend | $0.36 | +20.53% |
2003-12-22 | Dividend | $0.30 | +379.37% |
2003-12-16 | Dividend | $0.06 | -74.39% |
2002-12-23 | Dividend | $0.25 | +1,669.78% |
2001-12-24 | Dividend | $0.01 | -- |
IXJ Dividends vs. Peers
IXJ's dividend yield currently ranks #1 of 47 vs. its peers in the Health & Biotech ETFs category.